Sinovac Biotech (SVA) Shares Outstanding (Diluted) (2009 - 2026)
Sinovac Biotech's Weighted Average Shares Outstanding (Diluted) was 71.86 million in Q2 2026, unchanged from 71.86 million a year earlier.
Powered by 
Analysis
Sinovac Biotech (SVA) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends
From Q4 2009 onward, Sinovac Biotech has reported Weighted Average Shares Outstanding (Diluted) for 54 quarters.
- Weighted Average Shares Outstanding (Diluted) shows a five-year compound annual growth rate of -8.8% (FY2020 to FY2025).
- In earlier years, Weighted Average Shares Outstanding (Diluted) was 71.86 million in FY2024 (-27.9%), 99.61 million in FY2023 (-12.8%), 114.17 million in FY2022 (+0.1%) and 114.01 million in FY2021 (+0.3%).
- Quarterly Weighted Average Shares Outstanding (Diluted) has moved between 71.86 million (Q4 2024) and 114.17 million (Q2 2023) over five years.
- The best year-over-year quarter for Weighted Average Shares Outstanding (Diluted) over five years was Q2 2022 (growth of 0.3%); the worst was Q4 2024 (a decline of 27.9%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 893.40 Mn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 2.45 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 1.77 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 2.48 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | 1.96 Bn |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 1.56 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 546.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 1.25 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 5.75 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -24.98 Bn | - | 71.86 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 71.86 Mn |
| Dec 31, 2025 | 71.86 Mn |
| Jun 30, 2025 | 71.86 Mn |
| Dec 31, 2024 | 71.86 Mn |
| Jun 30, 2024 | 99.61 Mn |
| Dec 31, 2023 | 99.61 Mn |
| Jun 30, 2023 | 114.17 Mn |
| Dec 31, 2022 | 114.17 Mn |
| Jun 30, 2022 | 114.01 Mn |
| Dec 31, 2021 | 114.01 Mn |
| Jun 30, 2021 | 113.66 Mn |
| Dec 31, 2020 | 113.66 Mn |
| Sep 30, 2020 | 109.69 Mn |
| Jun 30, 2020 | 109.69 Mn |
| Mar 31, 2020 | 109.69 Mn |
| Dec 31, 2019 | 109.69 Mn |
| Sep 30, 2019 | 64.98 Mn |
| Jun 30, 2019 | 64.98 Mn |
| Mar 31, 2019 | 64.98 Mn |
| Dec 31, 2018 | 64.98 Mn |
API Access
Sinovac Biotech Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();